Who
Susan Ann Williamson
EVP & Chief Compliance Officer
Company insider
Files Form 4 as: EVP & Chief Compliance Officer, Keenova Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jul 2025
- Last trade
- 21 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jul 2026filed 23 Jul 2026 | Keenova Therapeutics | SEC FORM 4 Code F | —571 | filing |
| 21 Jul 2026filed 23 Jul 2026 | Keenova Therapeutics | SEC FORM 4 Code F | —571 | filing |
| 23 Apr 2026filed 24 Apr 2026 | Keenova Therapeutics | SEC FORM 4 Code M | —1,305 | filing |
| 23 Apr 2026filed 24 Apr 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code M | —1,305 at $0.00 | filing |
| 23 Apr 2026filed 24 Apr 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code M | —1,305 at $0.00 | filing |
| 23 Apr 2026filed 24 Apr 2026 | Keenova Therapeutics | SEC FORM 4 Code M | —1,305 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —15,936 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Keenova Therapeuticsoption or derivative | SEC FORM 4 Code A | —15,936 at $0.00 | filing |
| 31 Jul 2025filed 4 Aug 2025 | Mallinckrodtoption or derivative | SEC FORM 4 Code A | —9,774 at $0.00 | filing |
| 31 Jul 2025filed 4 Aug 2025 | Mallinckrodt | SEC FORM 4 Code A | —726 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.